ArticleReproductive medicine and biology2019
Addition of granulosa cells collected from differential follicle stages supports development of oocytes derived from porcine early antral follicles.
Article in Reproductive medicine and biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
- Spheroid granulosa cell supplementation improves granulosa cell-oocyte interactions and enhances in vitro growth of oocytes in cows.The Journal of reproduction and development · 2026Article
- Addition of granulosa cells collected from differential follicle stages supports development of oocytes derived from porcine early antral follicles.Reproductive medicine and biology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeImprovement of in vitro oocyte growth by addition of granulosa cells derived from differential developmental stages of follicles.
methodsGranulosa cells (GCs) collected from either early antral follicles (EAFs) or antral follicles (AFs) were added to oocyte-granulosa cell complexes (OGCs) derived from EAFs, and the in vitro growth of the oocytes was evaluated.
resultsGranulosa cells were incorporated into OGCs to form new OGCs within 2 days of culture. After 14 days of culture, the number of GCs surrounding oocytes was similar among the three OGCs conditions (unmanipulated "natural OGCs," "EAF-GCs add OGCs," and "AF-GCs add OGCs"), whereas the survival rate of the GCs and diameter of oocytes grown in vitro were the greatest for "AF-GCs added OGCs." After parthenogenetic activation, developmental rate till the blastocyst stage tended to be higher for "AF-GCs add OGCs" compared with other groups. Addition of AF-GCs significantly increased a hypoxic marker (pimonidazole staining) and increased the lipid content in oocytes grown in vitro compared with unmanipulated OGCs.
conclusionAddition of GCs derived from more advanced stages of follicles to the OGCs changes the metabolism of oocytes and is beneficial for in vitro growth of oocytes derived from EAFs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.